- Podcast
- 26/07/2024
- UK
Aspirin For Thromboembolic Prophylaxis
Description
In this episode of the BJJ podcast for July, host Andrew Duckworth welcomes esteemed guests, including Professor Ian Harris, Professor Samuel MacDessi, and Professor Fares Haddad, to discuss the emerging role of aspirin in thromboembolic prophylaxis for patients undergoing total hip and knee replacements. The conversation focuses on recent trends in VTE (venous thromboembolism) management, highlighting changes in institutional practices over the past decade regarding the use of low molecular weight heparin (clexane) and aspirin. They examine notable studies, including the PEP trial and EPCAT II, and introduce the pivotal CRISTAL trial, which compares the efficacy of low-dose aspirin to low molecular weight heparin in VTE prevention. The podcast provides valuable insights into the evolving landscape of prophylaxis practices, the significance of risk stratification in patient management, and the evidence-based implications for surgeons. The guests emphasize the importance of high-quality research in driving clinical decisions and consider the complexities of patient care, including cost-effectiveness and risk assessment in VTE prophylaxis.